OCULIS HOLDING AG (OCS) Forecast, Price Target & Analyst Ratings
NASDAQ:OCS • CH1242303498
27.42 USD
+0.46 (+1.71%)
At close: Mar 9, 2026
27.42 USD
0 (0%)
After Hours: 3/9/2026, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OCULIS HOLDING AG (OCS).
Forecast Snapshot
Consensus Price Target
$44.88
+ 63.68% Upside
Next Earnings Forecast
Release DateMay 7, 2026
PeriodQ1 / 2026
EPS Estimate-CHF0.48
Revenue Estimate202K
ChartMill Buy Consensus
86.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$44.88
Upside
+ 63.68%
From current price of $27.42 to mean target of $44.88, Based on 15 analyst forecasts
Low
$29.29
Median
$46.41
High
$57.75
Price Target Revisions
1 Month
0.00%
3 Months
-0.25%
Price Target Summary
15 Wall Street analysts provided a forecast for the next 12 months for OCS. The average price target is 44.88 USD. This implies a price increase of 63.68% is expected in the next year compared to the current price of 27.42.
The average price target has been revised downward by 0.25% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
86.67%
OCS was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about OCS.
In the previous month the buy percentage consensus was at a similar level.
OCS was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Stifel | Maintains | Buy -> Buy |
| 2026-03-04 | Needham | Maintains | Buy -> Buy |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-19 | Stifel | Maintains | Buy -> Buy |
| 2025-12-19 | JP Morgan | Initiate | Overweight |
| 2025-12-03 | LifeSci Capital | Initiate | Outperform |
| 2025-11-13 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-11 | Needham | Reiterate | Buy -> Buy |
| 2025-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-10-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-27 | Needham | Initiate | Buy |
| 2025-08-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-13 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 7, 2026
PeriodQ1 / 2026
EPS Estimate-CHF0.48
Revenue Estimate202K
Revenue Q2Q-29.12%
EPS Q2Q30.11%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-14.29%
EPS (1 Month)
0.00%
EPS (3 Months)
1.82%
Next Earnings Summary
OCS is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.48 USD and the consensus revenue estimate is 202.00K USD.
The next earnings revenue estimate has been revised downward by 14.29% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 892.34% | N/A 348.71% | N/A -37.61% | N/A 190.35% | N/A 43.43% | N/A 54.49% | N/A 31.59% | |||||||
| EBITDA YoY % growth | -12.11M | -12.99M -7.27% | -32.08M -146.96% | -45.564M -42.03% | -72.798M -59.77% | -81.126M -11.44% | N/A -26.74% | N/A -6.19% | N/A 227.66% | N/A -133.08% | N/A 723.58% | N/A 134.00% | N/A 88.16% | N/A 43.52% | |
| EBIT YoY % growth | -12.34M | -13.23M -7.21% | -32.38M -144.75% | -45.851M -41.60% | -73.204M -59.66% | -81.672M -11.57% | N/A -22.34% | N/A -11.67% | N/A 121.84% | N/A -570.78% | N/A 215.77% | N/A 186.04% | N/A 88.28% | N/A 42.20% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.53 | -2.10 -37.25% | -1.90 9.58% | N/A 0.34% | N/A -9.76% | N/A 130.02% | N/A -333.07% | N/A 225.03% | N/A 46.09% | N/A 92.10% | N/A 35.26% |
All data in CHF
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.48 30.11% | -0.49 0.55% | -0.49 -53.08% | -0.50 -25.34% |
| Revenue Q2Q % growth | 202K -29.12% | 202K -22.61% | 202K -16.87% | 202K -48.34% |
| EBITDA Q2Q % growth | -24.24M -22.11% | -24.24M -18.06% | -24.24M -21.76% | -24.24M -20.68% |
| EBIT Q2Q % growth | -24.24M -21.36% | -24.24M -16.72% | -24.24M -19.43% | -24.24M -17.48% |
All data in CHF
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
32.54%
EPS Next 5 Year
24.21%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
606.25%
Revenue Next 5 Year
263.90%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
55.03%
EBIT Next 5 Year
40.94%
OCULIS HOLDING AG / OCS Forecast FAQ
What do analysts expect the price target to be for OCULIS HOLDING AG (OCS)?
15 analysts have analysed OCS and the average price target is 44.88 USD. This implies a price increase of 63.68% is expected in the next year compared to the current price of 27.42.
Can you provide the upcoming earnings date for OCULIS HOLDING AG?
OCULIS HOLDING AG (OCS) will report earnings on 2026-05-07, before the market open.
Can you provide the consensus estimates for OCULIS HOLDING AG next earnings?
The consensus EPS estimate for the next earnings of OCULIS HOLDING AG (OCS) is -0.48 USD and the consensus revenue estimate is 202.00K USD.
How do analysts rate OCULIS HOLDING AG (OCS)?
The consensus rating for OCULIS HOLDING AG (OCS) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.